"Hanmi recognized as the No.1 R&D investing company in Korea, developing next generation Platform Technologies & new drugs on the fields of oncology, metabolic disorders and rare diseases. Hanmi has worked closely with global partners on various co-developments and collaborations. We are continuing to further expand through ""Open Innovation Strategy"" by finding potential partners for innovative solutions. No.1 R&D Investing Company in Korea. "